SCHEMBL22711765

SCHEMBL22711765

CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@H](Cn1c2nc(=O)[nH]c(=O)c-2nc2cc(C)c(C)cc21)OC(=O)CCC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 1.00
KMT2A Q03164 7/20 1.00
HTT P42858 4/20 1.00
HAT1 O14929 4/20 1.00
RBBP7 Q16576 4/20 1.00
KDM4E B2RXH2 5/20 0.54
USP2 O75604 4/20 0.54
MAPT P10636 4/20 0.54
TDP1 Q9NUW8 3/20 0.54
RXFP1 Q9HBX9 2/20 0.54
IDO1 P14902 1/20 0.54
RECQL P46063 3/20 0.52
CASP7 P55210 3/20 0.52
CASP1 P29466 2/20 0.52
BRCA1 P38398 2/20 0.52
HSD17B10 Q99714 2/20 0.52
TST Q16762 2/20 0.52
ALDH1A1 P00352 2/20 0.52
HPGD P15428 2/20 0.52
LMNA P02545 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30113081 1.00 MEN1 (1.00) MEN1KMT2AHTTHAT1RBBP7
SCHEMBL182061 1.00 MEN1 (1.00) MEN1KMT2AHTTHAT1RBBP7
SCHEMBL182062 1.00 MEN1 (1.00) MEN1KMT2AHTTHAT1RBBP7
SCHEMBL29940644 1.00 MEN1 (1.00) MEN1KMT2AHTTHAT1RBBP7
SCHEMBL31029204 0.94 MEN1 (0.88) MEN1KMT2AHTTHAT1RBBP7
SCHEMBL31029243 0.91 MEN1 (0.84) MEN1KMT2AHTTHAT1RBBP7
SCHEMBL31029223 0.91 MEN1 (0.84) MEN1KMT2AHTTHAT1RBBP7
SCHEMBL19192224 0.90 MEN1 (0.82) MEN1KMT2AHTTHAT1RBBP7
SCHEMBL15908089 0.90 MEN1 (0.81) MEN1KMT2AHTTHAT1RBBP7
SCHEMBL15909982 0.89 MEN1 (0.80) MEN1KMT2AHTTHAT1RBBP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188117-A1 C-Terminal Peptide Modification TECHNISCHE UNIVERSITEIT DELFT (NL) 2025-06-12 US disclosed
US-20240199686-A1 C-Terminal Peptide Modification TECHNISCHE UNIVERSITEIT DELFT (NL) 2024-06-20 US disclosed
US-11952457-B2 Bioabsorbable resin for additive manufacturing with non-cytotoxic photoinitiator CARBON, INC. (US) 2024-04-09 US disclosed
EP-4314007-A1 C-TERMINAL PEPTIDE MODIFICATION Technische Universiteit Delft (NL) 2024-02-07 EP disclosed
EP-4308582-A1 C-TERMINAL PEPTIDE MODIFICATION Technische Universiteit Delft (NL) 2024-01-24 EP disclosed
CN-116120585-B Preparation method for preparing amino acid photocatalytic decarboxylation oxidation product by means of photocatalyst 北京化工大学 2023-11-14 CN disclosed
CN-117062825-A C-terminal peptide modification 代尔夫特科技大学 2023-11-14 CN disclosed
CN-117015550-A C-terminal peptide modification 代尔夫特科技大学 2023-11-07 CN disclosed
CN-116120585-A Preparation method for preparing amino acid photocatalytic decarboxylation oxidation product by means of photocatalyst 北京化工大学 2023-05-16 CN disclosed
US-20230148252-A1 PROCESS FOR TREATING KERATIN MATERIALS USING A FLAVIN DERIVATIVE, A POLYMERIZABLE MOLECULE AND LIGHT RADIATION L'OREAL (FR) 2023-05-11 US disclosed
US-20230002550-A1 BIOABSORBABLE RESIN FOR ADDITIVE MANUFACTURING WITH NON-CYTOTOXIC PHOTOINITIATOR CARBON INC (US) 2023-01-05 US disclosed
WO-2022203512-A1 C-TERMINAL PEPTIDE MODIFICATION TECHNISCHE UNIVERSITEIT DELFT (NL) 2022-09-29 WO disclosed
WO-2022197184-A1 C-TERMINAL PEPTIDE MODIFICATION TECHNISCHE UNIVERSITEIT DELFT (NL) 2022-09-22 WO disclosed
EP-3727318-B1 PROCESS FOR TREATING KERATIN MATERIALS USING A FLAVIN DERIVATIVE, A POLYMERIZABLE MOLECULE AND LIGHT RADIATION OREAL (FR) 2022-01-19 EP disclosed
US-20200375866-A1 HAIR TREATMENT PROCESS USING A FLAVIN DERIVATIVE AND LIGHT RADIATION L'OREAL (FR) 2020-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230148252-A1 PROCESS FOR TREATING KERATIN MATERIALS USING A FLAVIN DERIVATIVE, A POLYMERIZABLE MOLECULE AND LIGHT RADIATION KRT18, FLNA, VIM MEN1 3617/4885KMT2A 1288/4885HTT 3548/4885
US-20240199686-A1 C-Terminal Peptide Modification PTMS, NGLY1, QPCT MEN1 211/4885KMT2A 3164/4885HTT 1218/4885
US-20250188117-A1 C-Terminal Peptide Modification PTMS, NGLY1, QPCT MEN1 276/4885KMT2A 3163/4885HTT 1309/4885
US-20200375866-A1 HAIR TREATMENT PROCESS USING A FLAVIN DERIVATIVE AND LIGHT RADIATION FH, BLVRB, NQO1 MEN1 2096/4885KMT2A 2399/4885HTT 607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.